News Item

Mar 29, 2017
VERSANTIS RAISES CHF 4.4 MILLION IN SERIES A FINANCING TO ADVANCE NEW GENERATION OF LIVER DISEASE MEDICINES

Funding brings resources to advance lead candidate VS-01 to first-in-human study and transform the care of patients with rare and life-threatening liver diseases.